← Leaderboards
Nicholas Chiorazzi
Feinstein Institute For Medical Research
$6,701,765
Attributed
$8,027,142
Total exposure
19
Grants
14
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.2M · FY2005–24$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$18,998,790 · 20
By mechanism
M01$11,945,779 · 15
R01$6,853,331 · 4
S07$199,680 · 1
Top collaborators
- Barbara A Sherry5 shared
Most similar at Feinstein Institute For Medical Research
Same institution · by research overlap
- Barbara A Sherry$3,575,522
- Daniel Griffin$3,815
- Shih-Shih Chen$167,500
Others in their field
Top investigators on “Chronic Lymphocytic Leukemia”
- David Heimbrook · Leidos Biomedical Research, Inc.$30,232,142
- Catherine Ju-Ying Wu · Broad Institute, Inc.$27,924,233
- John C Byrd · University Of Cincinnati$23,347,401
- Gregory H Reaman · National Childhood Cancer Foundation$17,052,970
- Susan L Slager · Mayo Clinic Rochester$15,712,869
- Thomas J. Kipps · University Of California San Diego$14,051,126
Research focus
Chronic Lymphocytic LeukemiaGene MutationApoptosisHuman SubjectAutoantigensResearch PersonnelFundingB-LymphocytesB LymphocyteCellsSourceGene ExpressionBloodBaseClinical ResearchNeoplasm /Cancer GeneticsAntigen ReceptorsFutureElementsGrantBiologyAffectAgingCell Survival
Grant awards (41)
Th17 generation, action and therapeutic relevance in chronic lymphocytic leukemia$523,308
R01 · FY2024 · CA · contact PI
Th17 generation, action and therapeutic relevance in chronic lymphocytic leukemia$540,466
R01 · FY2023 · CA · contact PI
Th17 generation, action and therapeutic relevance in chronic lymphocytic leukemia$503,583
R01 · FY2022 · CA · contact PI
Th17 generation, action and therapeutic relevance in chronic lymphocytic leukemia$560,038
R01 · FY2021 · CA · contact PI
Th17 generation, action and therapeutic relevance in chronic lymphocytic leukemia$523,359
R01 · FY2020 · CA · contact PI
B-cell repertoires in chronic lymphocytic leukemia$311,150
R01 · FY2012 · CA · contact PI
B-cell repertoires in chronic lymphocytic leukemia$311,150
R01 · FY2011 · CA · contact PI
B-cell repertoires in chronic lymphocytic leukemia$320,773
R01 · FY2010 · CA · contact PI
HUMAN BLOOD CELL DISORDERS TISSUE BANK$97,926
M01 · FY2010 · RR · contact PI
CHARACTERIZATION OF PROLIFERATING COMPARTMENT IN B-CELL CLL PATIENTS$18,653
M01 · FY2010 · RR · contact PI
B-CLL SUBGROUPS: MATURATION STAGE & GENE EXPRESSION$423
M01 · FY2010 · RR · contact PI
B-cell repertoires in chronic lymphocytic leukemia$320,773
R01 · FY2009 · CA · contact PI
B-CLL SUBGROUPS: MATURATION STAGE & GENE EXPRESSION$27,153
M01 · FY2009 · RR · contact PI
CHARACTERIZATION OF PROLIFERATING COMPARTMENT IN B-CELL CLL PATIENTS$19,611
M01 · FY2009 · RR · contact PI
B-CLL SUBGROUPS: MATURATION STAGE & GENE EXPRESSION$152,850
M01 · FY2008 · RR · contact PI
CHARACTERIZATION OF PROLIFERATING COMPARTMENT IN B-CELL CLL PATIENTS$46,040
M01 · FY2008 · RR · contact PI
B-CLL SUBGROUPS: MATURATION STAGE & GENE EXPRESSION$135,782
M01 · FY2007 · RR · contact PI
CHARACTERIZATION OF PROLIFERATING COMPARTMENT IN B-CELL CLL PATIENTS$40,538
M01 · FY2007 · RR · contact PI
General Clinical Research Center$2,943,468
M01 · FY2006 · RR · contact PI
B-CLL SUBGROUPS: MATURATION STAGE & GENE EXPRESSION$91,864
M01 · FY2006 · RR · contact PI
CHARACTERIZATION OF PROLIFERATING COMPARTMENT IN B CELL CHRONIC LYMPHOCYTIC LEUK$8,492
M01 · FY2006 · RR · contact PI
DIRECT MEASUREMENT OF LEUKEMIC CELL TURNOVER (SYNTHESIS AND REMOVAL) IN PATIENTS$6,176
M01 · FY2006 · RR · contact PI
General Clinical Research Center$3,014,306
M01 · FY2005 · RR
DIRECT MEASUREMENT OF LEUKEMIC CELL TURNOVER (SYNTHESIS AND REMOVAL) IN PATIENTS$99,036
M01 · FY2005 · RR
B-CLL SUBGROUPS: MATURATION STAGE &GENE EXPRESSION$49,028
M01 · FY2005 · RR
General Clinical Research Center$2,855,849
M01 · FY2004 · RR
B CELL REPERTOIRES IN CHRONIC LYMPHOCYTIC LEUKEMIA$307,679
R01 · FY2004 · CA
B CLL SUBGROUPS--MATURATION STAGE AND GENE EXPRESSION$272,240
R01 · FY2004 · CA
B-CLL Subgroups: Maturation Stage &Gene Expression$164,146
M01 · FY2004 · RR
B CLL SUBGROUPS--MATURATION STAGE AND GENE EXPRESSION$62,866
R01 · FY2004 · CA
Direct Measurement of Leukemic Cell Turnover$16,413
M01 · FY2004 · RR
General Clinical Research Center$2,158,025
M01 · FY2003 · RR
B CELL REPERTOIRES IN CHRONIC LYMPHOCYTIC LEUKEMIA$301,296
R01 · FY2003 · CA
B CLL SUBGROUPS--MATURATION STAGE AND GENE EXPRESSION$272,240
R01 · FY2003 · CA
B CELL REPERTOIRES IN CHRONIC LYMPHOCYTIC LEUKEMIA$295,100
R01 · FY2002 · CA
B CLL SUBGROUPS--MATURATION STAGE AND GENE EXPRESSION$272,240
R01 · FY2002 · CA
IRB Oversight and Educational Enhancement Program$199,680
S07 · FY2002 · RR
B CELL REPERTOIRES IN CHRONIC LYMPHOCYTIC LEUKEMIA$289,083
R01 · FY2001 · CA
B CLL SUBGROUPS--MATURATION STAGE AND GENE EXPRESSION$272,240
R01 · FY2001 · CA
SEROLOGIC, CELLULAR/MOLECULAR STUDIES OF AUTOANTIBODIES$310,508
R01 · FY2000 · AI
B CELL REPERTOIRES IN CHRONIC LYMPHOCYTIC LEUKEMIA$283,239
R01 · FY2000 · CA